查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608936

畜牧藥品市場：依功效、給藥途徑、家畜、通路分類 - 全球預測 2025-2030

Livestock Medicine Market by Medication (Drugs, Medicated Feed Additives, Vaccines), Route of Administration (Injectable, Oral, Topical), Livestock Animals, Distribution Channels - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年畜牧藥品市場價值為169.2億美元，預計到2024年將達到179.2億美元，複合年成長率為5.60%，到2030年將達到247.8億美元。

畜牧藥品包括維持和改善畜禽健康和生產力的藥品、疫苗、飼料添加劑和其他保健食品。這一領域對於滿足世界對動物源產品不斷成長的需求至關重要，並且需要改進牲畜保健方法。應用範圍從疫苗接種計劃等預防措施到對抗家禽、牛、豬和其他牲畜疾病的治療劑。最終用途包括農場、獸醫院、動物照護中心等。肉類和乳製品消費量的增加、獸醫技術的進步、動物健康意識的提高以及支持牲畜福利的法律規範推動了市場成長。新興市場的快速都市化和收入增加將進一步推動對優質畜產品的需求，帶來巨大的成長機會。然而，挑戰依然存在，包括嚴格的監管、高昂的開發成本以及與抗生素抗藥性相關的問題。原料價格的波動和新興的通用感染疾病增加了市場動態的複雜性。新疫苗的開發、精準畜牧技術以及益生菌和植物來源添加劑等抗生素替代品等領域的創新可能會蓬勃發展。製藥公司和農業綜合相關企業之間的策略聯盟可以產生協同效應並加強產品供應和分銷管道。為了利用潛在的機會，相關人員應專注於旨在永續解決方案的研發投資，並優先考慮與監管機構的透明溝通，以加快產品核可。此外，透過利用資料分析進行預測疾病建模和客製化治療計劃，可以顯著最佳化動物健康管理。透過專注於這些創新路徑並透過策略規劃和合作克服現有挑戰，市場參與企業可以有效地利用畜牧藥品市場現有和新興的機會。

主要市場統計
基準年[2023] 169.2億美元
預計年份 [2024] 179.2億美元
預測年份 [2030] 247.8億美元
複合年成長率（%） 5.60%

市場動態：快速發展的畜牧藥品市場的關鍵市場洞察

供需的動態交互作用正在改變牲畜藥品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球牲畜數量增加
    • 牲畜傳染病爆發
    • 增加牲畜疫苗的使用
  • 市場限制因素
    • 發展中地區牲畜藥物的供應與認知有限
    • 存在假冒偽劣藥品
  • 市場機會
    • 人們對牲畜健康和福利的認知不斷增強
    • 畜牧業投資快速成長
    • 畜牧新藥開發研究與開發
  • 市場挑戰
    • 增加牲畜的抗菌素抗藥性
    • 藥物可能對牲畜產生不利影響

波特五力戰略工具駕馭畜牧藥品市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解畜牧藥品市場的外部影響

外部宏觀環境因素對畜牧藥品市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解畜牧藥品市場競爭狀況

獸藥市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 獸藥市場定位矩陣供應商績效評估

FPNV定位矩陣是評估畜牧藥品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃獸藥市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對牲畜藥品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球牲畜數量增加
      • 畜禽傳染病發生現狀
      • 增加牲畜疫苗的使用
    • 抑制因素
      • 發展中地區牲畜藥物的供應與認知有限
      • 存在假冒偽劣藥品
    • 機會
      • 提高牲畜健康和保健意識
      • 畜牧業投資快速成長
      • 畜牧新藥開發研究與開發
    • 任務
      • 增加牲畜的抗菌素抗藥性
      • 藥物對牲畜的潛在不良影響
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章畜牧藥品市場依藥品分類

  • 藥品
    • 抗感染
    • 發炎（藥
    • 驅蟲藥
  • 醫藥添加劑和飼料添加劑
    • 胺基酸
    • 抗生素
    • 抗氧化劑
    • 酵素
    • 益生元和益生菌
    • 維他命
  • 疫苗
    • 去活化疫苗
    • 減毒活病毒疫苗

第7章畜牧藥品市場：依管理途徑

  • 可注射的
  • 口服
  • 話題

第8章畜牧業醫藥市場

  • 牛
  • 魚
  • 家禽
  • 豬

第9章畜牧藥品市場依通路分類

  • 離線
    • 藥局
    • 獸醫診所
  • 線上

第10章美洲畜牧藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太畜牧藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲畜牧藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • HESTER BIOSCIENCES LIMITED
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Vetpharma Animal Health SL
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-FE3E5C0AE72F

The Livestock Medicine Market was valued at USD 16.92 billion in 2023, expected to reach USD 17.92 billion in 2024, and is projected to grow at a CAGR of 5.60%, to USD 24.78 billion by 2030.

Livestock medicine encompasses pharmaceuticals, vaccines, feed additives, and other health products designed to maintain and enhance the health and productivity of farm animals. This sector is critical for fulfilling the rising global demand for animal-derived products, necessitating advancements in livestock healthcare practices. Applications range from preventive measures, such as vaccination programs, to therapeutics addressing diseases that affect poultry, cattle, swine, and other livestock. The end-use scope includes farms, veterinary hospitals, and animal care centers. Market growth is driven by rising consumption of meat and dairy products, technological advancements in veterinary care, increased awareness of animal health, and regulatory frameworks supporting livestock welfare. Rapid urbanization and income growth in emerging markets further fuel demand for quality animal products, presenting significant opportunities. Yet, challenges persist, notably stringent regulations, high costs of development, and issues related to antibiotic resistance. The volatility of raw material prices and emerging zoonotic diseases add complexity to market dynamics. Innovation can thrive in areas like the development of novel vaccines, precision livestock farming technologies, and alternatives to antibiotics such as probiotics and plant-based additives. Strategic alliances between pharma companies and agricultural entities can create synergies, enhancing product offerings and distribution channels. To harness potential opportunities, stakeholders should focus on R&D investments aimed at sustainable solutions and prioritize transparent communication with regulatory bodies to expedite product approvals. Additionally, leveraging data analytics for predictive disease modeling and customizing treatment plans can significantly optimize animal health management. By concentrating on these innovation avenues and overcoming existing challenges through strategic planning and collaboration, market participants can effectively capitalize on existing and emerging opportunities in the livestock medicine market.

KEY MARKET STATISTICS
Base Year [2023] USD 16.92 billion
Estimated Year [2024] USD 17.92 billion
Forecast Year [2030] USD 24.78 billion
CAGR (%) 5.60%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Livestock Medicine Market

The Livestock Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth in livestock population globally
    • Incidences of livestock infectious diseases
    • Rising usage of vaccines among livestock
  • Market Restraints
    • Limited availability and awareness of livestock medicine in developing areas
    • Presence of counterfeit or substandard drugs
  • Market Opportunities
    • Increasing awareness for livestock health & wellness
    • Surge in investment in the livestock industry
    • R&D for novel livestock drug development
  • Market Challenges
    • Rise in antimicrobial resistance in livestock
    • Potential adverse impact of medication on livestock

Porter's Five Forces: A Strategic Tool for Navigating the Livestock Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Livestock Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Livestock Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Livestock Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Livestock Medicine Market

A detailed market share analysis in the Livestock Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Livestock Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Livestock Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Livestock Medicine Market

A strategic analysis of the Livestock Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Livestock Medicine Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc., HESTER BIOSCIENCES LIMITED, Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol S.A., Vetpharma Animal Health S.L., Virbac SA, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Livestock Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Medication, market is studied across Drugs, Medicated Feed Additives, and Vaccines. The Drugs is further studied across Anti-infectives, Anti-inflammatory, and Antiparasitic. The Medicated Feed Additives is further studied across Amino acids, Antibiotics, Antioxidants, Enzymes, Prebiotics & Probiotics, and Vitamins. The Vaccines is further studied across Killed Inactivated Vaccines and Modified Live Vaccines.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Livestock Animals, market is studied across Cattle, Fish, Poultry, and Swine.
  • Based on Distribution Channels, market is studied across Offline and Online. The Offline is further studied across Pharmacy and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in livestock population globally
      • 5.1.1.2. Incidences of livestock infectious diseases
      • 5.1.1.3. Rising usage of vaccines among livestock
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and awareness of livestock medicine in developing areas
      • 5.1.2.2. Presence of counterfeit or substandard drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing awareness for livestock health & wellness
      • 5.1.3.2. Surge in investment in the livestock industry
      • 5.1.3.3. R&D for novel livestock drug development
    • 5.1.4. Challenges
      • 5.1.4.1. Rise in antimicrobial resistance in livestock
      • 5.1.4.2. Potential adverse impact of medication on livestock
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Livestock Medicine Market, by Medication

  • 6.1. Introduction
  • 6.2. Drugs
    • 6.2.1. Anti-infectives
    • 6.2.2. Anti-inflammatory
    • 6.2.3. Antiparasitic
  • 6.3. Medicated Feed Additives
    • 6.3.1. Amino acids
    • 6.3.2. Antibiotics
    • 6.3.3. Antioxidants
    • 6.3.4. Enzymes
    • 6.3.5. Prebiotics & Probiotics
    • 6.3.6. Vitamins
  • 6.4. Vaccines
    • 6.4.1. Killed Inactivated Vaccines
    • 6.4.2. Modified Live Vaccines

7. Livestock Medicine Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Livestock Medicine Market, by Livestock Animals

  • 8.1. Introduction
  • 8.2. Cattle
  • 8.3. Fish
  • 8.4. Poultry
  • 8.5. Swine

9. Livestock Medicine Market, by Distribution Channels

  • 9.1. Introduction
  • 9.2. Offline
    • 9.2.1. Pharmacy
    • 9.2.2. Veterinary Clinics
  • 9.3. Online

10. Americas Livestock Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Livestock Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Livestock Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Biogenesis Bago SA
  • 2. Boehringer Ingelheim International GmbH
  • 3. Ceva Sante Animale
  • 4. Dechra Pharmaceuticals PLC
  • 5. Elanco Animal Health Inc.
  • 6. HESTER BIOSCIENCES LIMITED
  • 7. Indian Immunologicals Ltd.
  • 8. Merck & Co., Inc.
  • 9. Neogen Corporation
  • 10. Nutreco N.V.
  • 11. Phibro Animal Health Corporation
  • 12. Vetoquinol S.A.
  • 13. Vetpharma Animal Health S.L.
  • 14. Virbac SA
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. LIVESTOCK MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. LIVESTOCK MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. LIVESTOCK MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. LIVESTOCK MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LIVESTOCK MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LIVESTOCK MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIOXIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY KILLED INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY MODIFIED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN LIVESTOCK MEDICINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND LIVESTOCK MEDICINE MARKET S